Aspalathin
Names | |
---|---|
IUPAC name
3-(3,4-Dihydroxyphenyl)-1-[5-(β-D-glucopyranosyl)-2,4-dihydroxyphenyl]propan-1-one
| |
Systematic IUPAC name
3-(3,4-Dihydroxyphenyl)-1-{2,4-dihydroxy-5-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl}propan-1-one | |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChemSpider | |
ECHA InfoCard
|
100.233.299 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C21H24O11 | |
Molar mass | 452.412 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Aspalathin is a
It was first isolated in 1965 by chromatography.[2]
It has demonstrated
antidiabetic activity.[3]
References
External links
- Media related to Aspalathin at Wikimedia Commons